Crédit Agricole S.A. stock (FR0000045072): disclosure filing highlights derivatives activity
01.06.2026 - 22:57:24 | ad-hoc-news.deCrédit Agricole from France appeared in a new regulatory disclosure on 06/01/2026, when Crédit Agricole S.A. was named as the disclosing party in a UK Takeover Panel Form 8.3 related to Spire Healthcare Group, emphasizing the French bank’s role as a derivatives counterparty in the United Kingdom while its core listing remains on Euronext Paris, according to the Form 8.3 document published via the London market’s regulatory news service on 06/01/2026.
The Form 8.3 filing identifies Crédit Agricole S.A. in the context of derivative and related positions over Spire Healthcare shares, with the disclosure date of 06/01/2026 and a stated opening position, highlighting the group’s broader capital markets activities in Europe as of that day, according to the same UK Takeover Panel disclosure released on 06/01/2026.
The stock traded at EUR 15.32 on 06/01/2026 on Euronext Paris under the ticker ACA, reflecting modest day-to-day fluctuations and keeping the French banking group within its established recent range, according to Euronext trading data as of 06/01/2026.
For investors in the euro area, Crédit Agricole thus continues to represent one of France’s large listed banking stocks on Euronext Paris, while also appearing in specialist UK takeover disclosures through activities of its investment banking arm and related entities, according to the UK Form 8.3 publication dated 06/01/2026.
As of: 06/01/2026
By the editorial team - specialized in equity coverage.
At a glance
- Name: Credit Agricole
- Sector/industry: Banking and financial services
- Headquarters/country: Montrouge, France
- Core markets: France and selected European markets
- Key revenue drivers: Retail banking, corporate and investment banking, and asset management
- Home exchange/listing venue: Euronext Paris (ACA)
- Trading currency: EUR
Crédit Agricole S.A.: core business model
The group focuses on universal banking, combining French retail franchises with corporate and investment banking, insurance, and savings products that generate income primarily from net interest margins and fees on financial services.
What banks and research houses say about Crédit Agricole S.A.
No verified analyst coverage was identified at the time of publication.
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
Sentiment and reactions on Crédit Agricole S.A.
Market participants are likely to discuss Crédit Agricole’s appearance in the Spire Healthcare-related Form 8.3 filing alongside the performance of its Paris-listed shares.
Conclusion
The latest UK Form 8.3 filing dated 06/01/2026 places Crédit Agricole in the spotlight as a derivatives counterparty linked to Spire Healthcare while its main shares remain anchored on Euronext Paris. For equity watchers, the disclosure highlights the breadth of the French banking group’s capital markets activities beyond its domestic retail base without materially changing the current equity trading picture. As further regulatory filings or corporate updates emerge, investors can reassess how such market-facing roles interact with Crédit Agricole’s core French and European banking operations.
Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.
So schätzen die Börsenprofis Credit Agricole Aktien ein!
Für. Immer. Kostenlos.
